Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
02.12.2024 07:00:04

Implenia wins several major building construction contracts in Switzerland and Germany

Implenia
31.16 CHF 1.87%
Kaufen / Verkaufen

Implenia AG / Key word(s): Incoming Orders
Implenia wins several major building construction contracts in Switzerland and Germany

02.12.2024 / 07:00 CET/CEST


New administrative offices for the Swiss National Science Fund (SNSF) | TRON Research Building in Mainz | Large, sustainable housing development in Leipzig | New residential building in Munich | Contracts worth over CHF 160 million in total

Glattpark (Opfikon), 2 December 2024Implenia has won several attractive building construction contracts in Switzerland and Germany. All of them align well with the Group’s strategic focus on large and demanding projects, specialist skills and sustainability. In total, the contracts are worth more than CHF 160 million to Implenia.

 

Sustainable new administrative offices for the Swiss National Science Fund (SNSF) in Bern
Implenia, acting as total contractor, is about to build one of the most sustainable and innovative office buildings in Switzerland: the new SNSF administrative offices in the Bern district of WankdorfCity. This will provide a modern working environment for Switzerland’s most important institution fostering scientific research. The SNSF aims to achieve independent certification for the new building according to the Swiss Sustainable Construction Standard (SNBS) and its platinum quality seal. The energy balance of the building will be improved by using environmentally friendly, durable materials (native timber and recycled concrete). Building work starts in January 2025, and the approximately 350 employees of the SNSF are expected to move into their new workplace in 2027. For more information about the project: snf-wankdorf.ch

 

New TRON research building for cutting-edge medical research in Mainz
Together with joint venture partners Gemünden and Apleona, Implenia (technical lead) has been commissioned to build the new, approximately 10,000 m2 TRON research building within the grounds of the Mainz University Medical Center. The construction order was placed following a pre-construction phase in which the joint venture partners had worked out the plans up to the building permit stage in close collaboration with the client. The total order is worth over EUR 100 million, of which Implenia has a share of almost EUR 40 million. Construction is scheduled to start this year and the new building should be ready for occupancy in 2027.
TRON is a translational research institute that develops new diagnostics and active ingredients for immunotherapeutic treatment of serious diseases. The new laboratory building, located close to the university, will enable researchers from all over the world to collaborate on advancing the development of outstanding, cutting-edge medicine.

 

Large, sustainable residential development in Leipzig
In a joint venture with its partner GP Papenburg, Implenia is building a seven- to eight-story residential development for municipal corporation LWB (Leipziger Wohnungs- und Baugesellschaft mbH). This will consist of nine contiguous properties offering a total of 202 apartments. The buildings will also provide commercial space and community areas. The services provided by Implenia include planning, development and turnkey construction of the buildings and outdoor facilities. The project is being planned and realised to create low energy buildings that meet the Effizienzhaus 55 standard. The roofs are greened and will be partially used as roof gardens. Construction work begins in January 2025 with completion planned for April 2027.

 

New residential building in Munich: social, accessible homes in a central location
Implenia is building three residential buildings in Munich for BayernHeim GmbH. The buildings will house a total of 101 apartments, a large part of which will be publicly funded rental apartments, plus a commercial unit for neighbourhood supply and two underground car parks. The apartments are designed to be accessible for disabled people. The services provided by Implenia include detailed building design, planning of outdoor facilities and turnkey construction of the entire project. Construction is scheduled to start in January 2025, and completion is planned for July 2026.

 

In addition, Implenia has won the contract to build another phase of a residential neighbourhood at an ongoing project in Heilbronn, and has been commissioned with the pre-construction phase of a large public building project in Siegburg.

The new SNSF administrative offices in Bern: photovoltaic modules will be installed on the roof and facade. “Brise soleil” slats on the facade protect against heat (image: ©Penzel Valier AG).

The new TRON research building for cutting-edge medical research in Mainz (image: ©NICKL & PARTNER ARCHITEKTEN AG).

New residential building in Munich: social, accessible living in a central location (image: ©Zwischenräume Architekten + Stadtplaner GmbH).

Contact for media:
Corporate Communications, T +41 58 474 74 77, communication@implenia.com 

 

Contact for Investors and Analysts:
Investor Relations, T +41 58 474 35 04, ir@implenia.com 

Dates for investors:
26 February 2025: Annual results 2024, Analysts and Media Conference
25 March 2025: Annual General Meeting

As Switzerland’s leading construction and real estate service provider, Implenia develops, builds and manages homes, workplaces and infrastructure for future generations in Switzerland and Germany. It also offers tunnelling and related infrastructure services in other markets. Formed in 2006, the company can look back on around 150 years of construction tradition. Implenia brings together the know-how of its highly skilled development, planning and execution units under the umbrella of an integrated multinational construction and real estate service provider. With its broad offering and the expertise of its specialists, the Group realises large, complex projects and provides client-centric support across the entire life cycle of a building or structure. It focuses on client needs and on striking a sustainable balance between commercial success and social and environmental responsibility. Implenia, with its headquarters in Opfikon near Zurich, employs more than 9,000 (FTE) people across Europe and posted revenue of CHF 3.6 billion in 2023. The company is listed on the SIX Swiss Exchange (IMPN, CH0023868554). More information can be found at implenia.com.



End of Media Release


Language: English
Company: Implenia AG
Industriestrasse 24
8305 Dietlikon
Switzerland
Phone: +41 58 474 74 74
E-mail: info@implenia.com
Internet: www.implenia.com
ISIN: CH0023868554
Valor: A0JEGJ
Listed: SIX Swiss Exchange
EQS News ID: 2041689

 
End of News EQS News Service

2041689  02.12.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2041689&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu Implenia AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mut zum Risiko – BX Morningcall mit Dr. Ralf Seiz & François Bloch

🔔🔔🔔 Im heutigen BX Morningcall Spezial gibt Dr. Ralf Seiz, CEO und Gründer der Finreon AG, spannende Einblicke in innovative Anlagelösungen. Als Spin-off der Universität St. Gallen bietet Finreon Strategien an, die Diversifikation und Risikomanagement vereinen – unter anderem durch die systematische Reduktion von Aktienkonzentrationen und die Nutzung von Volatilitätsprämien.

Zusammen mit dem Investmentstrategen François Bloch und Olivia Hähnel von BX Swiss spricht der promovierte Ökonom auch über die aktuellen wirtschaftlichen Herausforderungen und gibt exklusive Einblicke in seine persönlichen Anlageprojekte.

👉🏽 https://bxplus.ch/bx-musterportfolio/

Mut zum Risiko – BX Morningcall mit Dr. Ralf Seiz & François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’136.59 19.95 BCASMU
Short 12’415.14 13.73 UBS07U
Short 12’860.91 8.94 UTBSOU
SMI-Kurs: 11’681.87 11.12.2024 17:31:29
Long 11’178.23 18.82 SSSMAU
Long 10’943.12 13.73 SSQMQU
Long 10’481.71 8.94 SS5M5U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten